XALATAN 50 micrograms/ml, eye drop solution in a single-dose container 30 single-dose containers of 0.2 ml
Active ingredients: Latanoprost
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solution30 single-dose containers of 0.2 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XALATAN 50 microgrammes/mL, collyre en solution en récipient unidose
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 30 (3 x 10) récipients unidose polyéthylène basse densité (PEBD) de 0,2 mL
- Marketing authorisation holder
- VIATRIS MEDICAL
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 May 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62161131CIP73027431CIP133400930274316Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LATANOPROSTcollyre | 50 microgrammes · 1 mL de collyre en solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.